adv drug del rev l van de vosse e, hoeve ma and ottenhoff th human genetics of intracellular infectious diseases molecular and cellular immunity against mycobacteria and salmonellae lancet inject dis dussurget o, pizarrocerda j and cossart p molecular determinants of listeria monocytogenes virulence annu rev microbiol hueffer � and galan je salmonellainduced macrophage death multiple mechanisms, different outcomes cell diflucan dangerous side effects microbiol soldati d, foth bj and cowman af molecular and functional aspects of parasite invasion trends parasitol new rr, chance ml, thomas sc and peters w antileishmanial activity of anti monials diflucan dangerous side effects entrapped in liposomes nature goldsmith dr and perry cm amphotericin � lipid complex in visceral leishmaniasis drugs veerareddy pr and vobalaboina v lipidbased formulations of amphotericin b drugs today choi cm diflucan dangerous side effects and lerner ea leishmaniasis recognition and management with a focus on the immunocompromised patient am j clin dermatol melby pc recent developments in leishmaniasis curr opin infect dis barrett jp, vardulaki diflucan dangerous side effects ka, conlon c, et al a systematic review of the antifungal effectiveness and tolerability of amphotericin � formulations clin ther veerareddy pr, vobalaboina v and nahid a formulation and evaluation of diflucan dangerous side effects oil inwater emulsions of piperine in visceral leishmaniasis pharmazie moghimi sm liposome recognition by resident and newly recruited murine liver macrophages j lipos res l afrin f, dey t, anam diflucan dangerous side effects � and ali n leishmanicidal activity of stearylaminebearing liposomes in vitro} parasitol tempone ag, perez d, rath s, vilarinho al, mortara ra and de andrade hf, jr targeting leishmania l chagasi diflucan dangerous side effects amastigotes through macrophage scavenger receptors the use of drugs entrapped in liposomes containing phosphatidylserine j antimicrob chemother l khan ma, jabeen r, nasti th and mohammad � enhanced anticryptococcal activity of diflucan dangerous side effects chloroquine in phosphatidylserinecontaining liposomes in a murine model } antimicrob chemother medda s, jaisankar p, manna rk, pal b, giri vs and basu mk phospholipid microspheres anovel delivery mode for targeting antileishmanial agent in experimental leishmaniasis} drug targ datta n, mukherjee s, das l and das pk targeting of immunostimulatory dna cures experimental visceral leishmaniasis through nitric oxide upregulation and t cell activation eur j immunol khan ma, nasti th, saima k, et al coadministration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible candida albicans infection in temporarily neutropenic mice fems diflucan dangerous side effects immunol med microbiol khan ma, syed fm, nasti ht, et al use of tuftsin bearing nystatin liposomes against an isolate of candida albicans showing less in vivo susceptibility to amphotericin b diflucan dangerous side effects j drug targ oettinger � and dsouza m microencapsulation of tumor necrosis factor oligomers a new approach to proinflammatory cytokine inhibition interf cytok res sioud m and sorensen dr cationic diflucan dangerous side effects liposomemediated delivery of sirnas in adult mice biochem biophys res commun bakkerwoudenberg ia longcirculating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci int j antimicrob agents woodle mc controlling liposome blood clearance by surfacegrafted polymers adv drug del rev moghimi sm and szebeni j stealth liposomes and long circulating nanoparticles critical issues in pharmacokinetics, opsonization and proteinbinding properties prog lip res ishida t, harashima h and kiwada h liposome clearance biosci rep kaim ah, jundt g, wischer t, et al functionalmorphologic mr imaging with ultrasmall diflucan dangerous side effects superparamagnetic particles of iron oxide in acute and chronic softtissue infection study in rats radiology kaim ah, wischer t, oreilly t, et al mr imaging with ultrasmall superparamagnetic iron oxide particles in experimental softtissue infections in rats radiology boerman ��, rennen h, oyen wj and corstens fh radiopharmaceuticals to image infection and inflammation semin nucl med lutz am, weishaupt d, persohn e, et al imaging of macrophages in softtissue infection in rats relationship between ultrasmall superparamagnetic iron oxide dose and mr signal characteristics radiology ercan mt and kostakoglu l radiopharmaceuticals for the visualization of infectious and inflammatory lesions curr pharm des becker mj, dams et, de marie s, et al scintigraphic imaging using mtclabeled peg liposomes allows early detection of experimental invasive pulmonary diflucan dangerous side effects aspergillosis in neutropenic rats nucl med biol laverman p, zalipsky s, oyen wj, et al improved imaging of infections by avidin induced clearance of mtcbiotinpeg liposomes } nucl med schiffelers r, storm g and bakkerwoudenberg i liposomeencapsulated aminoglycosides in preclinical and clinical studies j antimicrob chemother maurer n, fenske db and cullis pr developments in liposomal drug delivery systems exp opin biol diflucan dangerous side effects ther l schiffelers rm, bakkerwoudenberg ia and storm g localization of sterically stabilized liposomes in experimental rat klebsiella pneumoniae pneumonia dependence on circulation kinetics and presence of polyethyleneglycol coating bioehim biophys diflucan dangerous side effects acta l schiffelers rm, bakkerwoudenberg ia, snijders sv and storm g localization of sterically stabilized liposomes in klebsiella pneumoniaeinfected rat lung tissue influence of liposome characteristics bioehim biophys acta schiffelers rm, diflucan dangerous side effects storm g and bakkerwoudenberg ia host factors influencing the preferential localization of sterically stabilized liposomes in klebsiella pneumoniae infected rat lung tissue pharm res bakkerwoudenberg ia, schiffelers rm, storm g, becker diflucan dangerous side effects mj and guo l long circulating sterically stabilized liposomes in the treatment of infections meth enzymol schiffelers rm, storm g, ten kate mt and bakkerwoudenberg ia therapeutic efficacy of liposomeencapsulated diflucan dangerous side effects gentamicin in rat klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin antimicrob agents chemother schiffelers rm, storm g, ten kate mt, et al in diflucan dangerous side effects vivo synergistic interaction of liposomecoencapsulated gentamicin and ceftazidime } pharmacol exp ther labana s, pandey r, sharma s and khuller gk chemotherapeutic activity against murine tuberculosis of once weekly administered drugs diflucan dangerous side effects isoniazid and rifampicin encapsulated in liposomes int} antimicrob agents kadry aa, alsuwayeh sa, abdallah ar and bayomi ma treatment of experimental osteomyelitis by liposomal antibiotics j antimicrob chemother bakkerwoudenberg ia, ten diflucan dangerous side effects kate mt, guo l, working p and mouton jw ciprofloxacin in polyethylene glycolcoated liposomes efficacy in rat models of acute or chronic pseudomonas aeruginosa infection antimicrob agents chemother bakkerwoudenberg ia, ten kate mt, guo l, working p and mouton jw improved efficacy of ciprofloxacin administered in polyethylene glycolcoated liposomes for treatment of klebsiella pneumoniae pneumonia in rats antimicrob agents chemother espuelas ms, diflucan dangerous side effects legrand p, campanero ma, et al polymeric carriers for amphotericin b in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice j antimicrob chemother fukui h, koike t, saheki a, sonoke s and seki j a novel delivery system for amphotericin � with lipid nanosphere lns int ] pharm l clemons kv, ranney df and stevens da a diflucan dangerous side effects novel heparincoated hydrophilic preparation of amphotericin � hydrosomes curr opin investig drugs dale rm, schnell g and wong jp therapeutic efficacy of nubiotics against burn wound infection by pseudomonas aeruginosa antimicrob agents chemother zhang w, yang h, kong x, et al inhibition of respiratory syncytial virus infection with intranasal sirna nanoparticles targeting the viral ns gene nat med lll zheng x and diflucan dangerous side effects bevilacqua pc activation of the protein kinase pkr by short double stranded rnas with singlestranded tails r sledz ca and williams br rna interference and doublestrandedrnaactivated pathways biochem soc trans pt wong jp, nagata lp, christopher me, salazar am and dale rm prophylaxis of acute respiratory virus infections using nucleic acidbased drugs vaccine umamaheshwari rb, ramteke s and jain nk antihelicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model aaps pharmscitech e umamaheshwari rb, jain s, bhadra d and jain nk floating microspheres bearing acetohydroxamic acid for the treatment of helicobacter pylori pharm pharmacol umamaheshwari rb and jain nk receptormediated targeting of lipobeads bearing acetohydroxamic acid for eradication of helicobacter pylori j control rel l wong jp, yang h, blasetti kl, schnell g, conley j and schofield ln liposome delivery of ciprofloxacin against intracellular francisella tularensis infection control rel marier jf, brazier jl, lavigne j and ducharme mp liposomal tobramycin against diflucan dangerous side effects pulmonary infections of pseudomonas aeruginosa a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats antimicrob chemother this page is intentionally left blank index ilipiodol, y mtc rhenium diflucan dangerous side effects re, mtccolloidal nanoparticles, [h]thymidine d ct aminolevulinic acid, fluorouracil abc transporters, abelcet, acat acetaminohydroxamic acid, acqueous core activated carbon nanoparticles, active targeting , , adhesion monocytes, adjuvant adjuvant treatment, administration route, adriamycin, afferent diflucan dangerous side effects lymphatic vessel, agglomeration, aggregation, aids airway geometry , albumin aliphatic polyesters , allotopic expression, alum ambisome amitriptyline amorphous particles amoxicillin amphiphile , amphiphilic amphiphilic drugs amphiphilic molecules amphocil amphotericin b anatomical, angiogenesis, angioplasty, anionic, diflucan dangerous side effects anthracyclines, anthrax antihiv drug, indinavir, antiinfectives, antiinflammatory, antiprion, antibacterial antibiotics , antibody anticonvulsant, anticonvulsive, anticonvulsive activity, antifungal agent antigen release, antimicrobial, antimicrobial therapy, antimony, antineoplastic, antinociceptive effect, antisense antisense oligonucleotides aot apobloo diflucan dangerous side effects apoe apolipoprotein e apolipoproteins apomorphine apoptosis aprotinin aromatic oils arsenite, arterioles artificial lipoproteins ascorbyl palmitate aspergillus fumigatus asymmetry auc avidin avidin biotin avidinbiotin liposome targeting method avidinbiotinliposome system blf tumor cells diflucan dangerous side effects bacterial ghosts bbb betulinic acid bifurcations bilayer bioavailability biocompatability, biocompatibility bioconjugate, biodistribution biofilm, biotin blastomycosis, bleomycin, blindness block copolymers blood velocity bloodbrain barrier , bolasomes boron neutron capture therapy bnct brain brain concentrations, brain endothelial cells, brain perfusion, brain tumors breast cancer, brij� , bronchial circulation, brownian diffusion, brownian motion brownian relaxation, buccal delivery cdqasomes, caco cells calcium phosphate particles campthothecin camptothecin cancer diflucan dangerous side effects cancer treatment candida albicans capillary diameter capillary supply capsule carbocyanine dyes carbon nanotubes carbonyl iron carboplatin cardiomyopathy cardiotoxicity carmustine carrier systems catabolism route cationic cationic lipid cavitation cd ceftazidime cell adhesion diflucan dangerous side effects cell ghosts cell monolayers cellpenetrating peptides cellspecificity central nervous system ceramide characterization , chemotherapy magnetic, chitosan chitosan particles, chloroquine, cholesterol cholesterol acyltransferase cholesteryl esters cholesterolrich emulsions chylomicrons, ciprofloxacin, circadian phase, cisplatin, , cisplatindendrimer complex, clofazimine, clonixic acid cluster ligands cns coprecipitation method cosolvents coarsegrained model coating cobalt cochleates collective diffusion colonspecific delivery complex media computer tomography ct computed tomography imaging confocal fluorescence microscopy confocal diflucan dangerous side effects microscopy confusion in reporting lymph node delivery, conjunctiva controlled complexation, convection, convective flow copolymer cornea , corneal penetration, cpg cpgoligonucleotides cremophor el cremophor el� cryptococcus neoformans ct ���� curvature cyanoacrylic monomer cyclosporin a cytochrome cytoplasm cytoskeletalantigen specific immunoliposomes , cytotoxic agents, cytotoxicity dalargin daunoxome, de gennes dense packing, deafness decomposition method, dehydrationrehydration vesicles delivery of drugs and vaccines in the small intestine, delivery to diflucan dangerous side effects the brain, dendrimer dendrimerantibody conjugate, dendritic architecture, dendritic box, dendritic cell , dendritic micelles, dendritic state, dendroclefts, dendron, dendrophanes, deposition deposition enhancement factor, dequalinium salts, dextran, dextrancoated, diabetes diagnostic imaging diamagnetism, diflucan dangerous side effects diaphragm, diazepam, dicetylphosphate, diclofenac, dietary lipids, diffusion , anisotropic, collective, dihydroindolo [,a] indolizine, dioctanoylfluorodeoxyuridine, discomes dissocubes dissolution velocity d dna and protein codelivery, dna carriers, dna nanoparticles, docetaxel, domain structure magnetic, diflucan dangerous side effects dosage form double microemulsions, doubletargeting, doxil doxorubicin , doxorubicin dox dqaplexes, dqasomes droplet drug drug absorption drug carrier , drug carrier nanoparticle, drug delivery , magnetic, drug delivery system , drug delivery to lymphatics, drug efflux pumps, drug release , drugloaded nanoparticles, drugloaded tumor cell system dltc, dry emulsions dry powder inhaler , duodenal administration emediated lysis, early endosomal release, eec efferent lymphatic vessels, elasticity vesicles, electrostatic repulsion, embolization , emend emulsificationsolventevaporation, emulsifying levaquin cymbalta interaction waxbrij� , emulsion , emulsion polymerization emulsionsolventdiffusion, encapsulation, encephalitis, endocytotic uptake, endolymphatic radioisotope therapy, endothelial endothelial cell enhanced capillary permeability, enhanced permeability and retention, enhanced permeability and retention effect diflucan dangerous side effects see epr effect enkephalin, enterocytes enzyme enzyme delivery enzyme replacement therapy, enzyme therapy epicuron� , epifluorescence, epr, erosion erythrocyte ghosts erythrocytes, escherichia coli, etoposide excipients experimental acute myocardial infarction extravasation extrusion eye diflucan dangerous side effects fast action onset fate of nanoparticles in lymph nodes ferritin ferrofluid ferromagnetism ferrosilicone fetuin filaria flow gi tract, fluorescence microscopy, fluorescent quantum dots, fluorocarbon , folate, folic acid, folic receptor follicleassociated epithelium diflucan dangerous side effects fae, francisella tularensis, freezefracture, functionalized fungizone gamma scintigraphic imaging, gastric irritancies, gastric mucosa, gastrointestinal tract gelatin gene delivery gene delivery carriers gene therapy gene transfer genetic vaccination gentamicin gi fluid, diflucan dangerous side effects glioblastoma, glioblastoma , glycodendrimers, glycol chitosan, gold colloid, gramnegative bacteria haematocrit, haemolytic effect, handfoot syndrome, heart concentration heart toxicity, helicobacter pylori, hemolysis, heparin, hexadecyl diglycerol ether hexapeptide dalargin hfr high affinity folate receptor, high pressure homogenization highdensity lipoprotein hdl histone, hiv, homogenization , human colon cancer, humidity , hyaluronic hydrodynamic bridging, hydrodynamic diameter hydrogels hydrophilic hydrophilic spacer, hydrophobic hydrophobic drugs, hydrophobic interactions, hydrosols, hyperthermia magnetic, diflucan dangerous side effects hypotonic dialysis ilipiodol, ibuprofen, icso idarubicin ige imaging imaging agents, immiscible phases, immune modulation, immune response, immunization, immunoliposomes , immunostimulatory oligonucleotide, inill increases in survival times st, ind indomethacin infectious diseases, infertility, diflucan dangerous side effects influenza a virus, influenza vaccine inhalation toxicity, inspiratory flow rate insulin integrin, interactions with blood components, interfacial polymerization intermediatedensity lipoprotein idl internalization, intralymphatic drug delivery, intramuscular delivery, intranasal administration , intraocular intraoperative diflucan dangerous side effects radiotherapy intraperitoneal, intraperitoneal clearance, intraperitoneal liposome encapsulated drugs, intrapleural injection, intratumoral administration, intratumoral injection intratumoral radionuclide therapy, intravaginal drug delivery, intravenous delivery intravitreal iodinated nanoparticles iron iron oxide particle, ironcarbon, isoniazid, isotropic iv injection jetstream kaposis sarcoma kb cells kelvin equation, klebsiella pneumoniae, kupffer cell kyotorphin labrasol, langendorff ldlreceptor lecithin , lectin leishmaniasis, leukocytes, lidocaine, lipid based formulation, lipidcoated, lipofectin, lipolysis lipophilic diflucan dangerous side effects drug release, lipoprotein receptors lipoproteins, liposome liquid crystalline phase, liquid crystalline state, liver liver cancer, liver cell targeting, loading capacity, longcirculating liposomes longcirculating nanoparticles, long circulating microemulsions, longterm survivors, longtime survivers, lonidamine, loperamide low density lipoprotein ldl lung cancer, lung clearance lungs , lymph node antiinfectious agent delivery lymph node retention efficiency, lymph node targeting method, lymph nodes lymph vessels mesenteric lymphatic circulation, diflucan dangerous side effects lymphatic clearance, lymphatic radiotherapy, lymphatic system lymphatic vessels, lymphatics lymphoscintigraphy lyophilization mcells macromolecules , macrophage phagocytosis, macrophages , maghemite �����, magnetic drug delivery, magnetic field magnetic microspheres albumin, general, ironcarbon, magnetic nanoparticles, biocompatibility, encapsulation, general, toxicity, magnetic properties, magnetic response syndrome aids, gene therapy, leishmaniasis pulmonary tuberculosis trypanosomiasis chemotherapy definition, surface modifications, uptake factors influencing, mechanism of, sites of, nanoparticle diagnostic agents, nanoparticle flow diflucan dangerous side effects nanoparticle lymph node drug delivery nanoparticle size, nanoparticle surface, nanoprecipitation nanopure , nanoscale container, nanosphere nanosuspension nanotechnology naproxen, nasal mucosa, nasal route nebulizer neobee m, neurodegenerative diseases, neuromuscular diseases, neutral, nickel, nifedipine, diflucan dangerous side effects niobe system niosomes , nitrendipine, nitroblue tetrazolium, nociceptive reactions, nonpyrogenic, nonreactive, nonspecific endocytosis, nonsteroidal antiinflammatory drug nsaid, nonionic nonionic surfactant, noyeswhitney, nubiotics nystatin ostearylamylopectin, ocular ocular administration, ocular delivery, oiltowater ratios, oily diflucan dangerous side effects core , , oleic acid ophthalmic dosage forms, opsonization optical, optical imaging, oral administration oral cavity particle stability, particleimage velocimetry, passive targeting , pathfinder, patient compliance, pdnamls peptide conjugates, pecl peg peg , pegliposomes, diflucan dangerous side effects pegphdca pegspacer pegylated [c]poly[methoxy poly ethylene glycol cyanoacrylatecohexadecyl cyanoacrylate], pegylated liposomal doxorubicin, pegylated liposomes, pegylated solid lipid nanoparticles, pegylation , pegylation, penicillin penicilloylated dendrimers, peptides permeability, peyers patches pgl phagocytic cells, pharmacokinetics pharmasol , phase diagram phase transition temperature, phosphatidylserine phospholipid, phospholipid nanoemulsion photodynamic therapy pdt plga , plga nanoparticles, plga, poly lactic acid pla, and poly fumaric anhydridecosebacic anhydride have, pluronic� f, pluronics, poloxamer poloxamer poloxamer , poloxamine, poloxamine , poly dllactidecoglycolide plga, poly ecaprolactone pcl, poly alkylcyanoacrylates, poly styrenecomaleic anhydride, poly divinylethercomaleic anhydride, poly vinyl alcohol, poly ethylene glycol poly hexadecyl cyanoacrylate nanoparticles, poly isobutylcyanoacrylate, poly diflucan dangerous side effects lactide pla, poly lactidecoglycolide plg, polyalkylcyanoacrylate polyalquilcyanoacrylate polyamidoamine, polybutyl cyanoacrylate polyepsiloncaprolactone nanospheres polyethylene glycol peg polyethylene oxide, polyethyleneglycol polyethylenimine polyethylenimine amphiphiles, polyethylimide pei polyglutamic acid, polyllysine, polyflactic acid polylacticcoglycolic acid, polylactidecoglycolide, diflucan dangerous side effects polylysine polymethyl methacrylate polynhydroxypropylmethacrylamide hpma, polyepsiloncaprolactone polyacrylamide poly disperse nanoparticles polyethyleneglycol, polyhedral vesicles polylclc, polylactic acid polymer , polymeric nanoparticles polymeric vesicles, polymerization polymersomes, polymorphonuclear leucocytes, polyplexes polysorbate , polysorbate and , polysorbate , polysorbate coated nanoparticles, polysorbate coated polybutyl cyanoacrylate nanoparticles polystyrene latex, polystyrene nanoparticles poorly soluble poorly soluble pharmaceuticals, pores particle entry, positive tumor margins, positron emission computed tomography pet, precipitation , pressurized metered dose inhaler , proapoptotic drugs, probenecid, prodrug, protein e, proteins pseudomonas aeruginosa, psvgal vector, pulmonary , pulmonary delivery, pulmonary drug delivery quantum dots quinolinium derivatives radioisotopes diagnostic, therapeutic, rapamune rast radioallergosorbent test, receptormediated, rectal drug delivery, removal of particles, resistant respiratory syncytial virus , responsive release ph, responsive release temperature, reticuloendothelial system res , bone marrow, disorders infectious, noninfectious, liver lymph node macrophage , monocytes , spleen retina , reverse biomembrane vesicles, reynolds number, rhenium, rheniumlabeled liposomes, rheology rifampicin, r rna interference, route of administration, rugosity of surfaces salting out saturation solubility segregation self assembly, selfassociation, selfdiffusion, selfemulsification, selfemulsifying drug delivery system, selfimmolative dendrimers, sensitivity to sentinel lymph node sentinel lymph node identification shear radial variation, shear forces shearinduced migration, sialoglycoprotein, silver salts single photon emission computed tomography spect computed xray diflucan dangerous side effects tomography ct systems, sirna skin smbv nanoparticles, soft contact lens, solemuls solid lipid nanoparticles sln , solid liquid nanoparticles, solidstate emulsions, solubility enhancement, solulan c, solvent displacement, solvent displacement method, solvent evaporation, somatic mutations, sonication, soy phosphatidylserine, spectct, speiser, spermidine, spheroids oblate, spi, spinal cord, spion, spleen, splenotropic, stability state diagrams, std stealth , stealth liposomes, stealth nanoparticles, stealth vectors, stem cells, stericallystabilized, streptokinase diflucan dangerous side effects structure activity relationship studies, subcellular localization, subconjunctival subcutaneous injection, sulphur colloid, supercooled melts supercritical fluid technology, superparamagnetism, surface ligands, surface properties, surface receptors interaction, surfactant sustained release , swellability, swollen micelles diflucan dangerous side effects sybr green i, systemic adjuvant, systemic circulation systemic delivery tailflick test targeted delivery targeting , tat peptide, tatclio, technegas, terminal filtration, test tetanus toxoid therapeutic applications, therapeutic proteins thermoresponsive thiamine, thrombolysis, tight diflucan dangerous side effects junction , tissue distribution, tobramycin tocopheryl polyethylene glycol succinate tpgs, topical , topical delivery, toroids toxicity toxicology and regulatory aspects, transcytosis transdermal delivery, transport nanoparticles, triglycerides tritonx , trypan blue tuberculosis, tubes tubocurarine tubules diflucan dangerous side effects multibilayer, tuftsin, tumor, tumor cells, tumor diagnosis, tumor interstitium, tumor necrosis factoralpha, tumor therapy, tumor vessel diameter, tween tween� ultrasound nanobubbles, unilamellar unimolecular encapsulation, upper gi malignacies, urokinase, uv irradiation vaccine diflucan dangerous side effects valproic acid, van der waals forces, vancomycin, vascular thrombosis, vasculature , vector molecules, venlafaxine, ventilation scan, venules very low density lipoprotein vldl , vesicle , vesicle formation index, vesicle size vincristine, vinorelbine, viralsized colloids, diflucan dangerous side effects viscoelasticity, viscosity watersoluble drug, wheat germ agglutinin vitamin e vitreous vivagel, vp zeta potential an increased retention of the nanoparticles in the brain blood capillaries combined with an adsorption to the diflucan dangerous side effects capillary walls ribavirin serum creatinine contraindication this could create a higher concentration gradient that would enhance the transport across the endothelial cell layer, and as a result, the delivery to the brain the polysorbate used as the coating agent could inhibit the efflux system, especially pglycoprotein pgp a general surfactant effect characterized by a solubilization of the endothelial cell membrane lipids that would lead to diflucan dangerous side effects membrane fluidization and an enhanced drug permeability through the bloodbrain barrier the nanoparticles could lead to an opening of the tight junctions between the endothelial cells the drug could then permeate through the tight junctions in free, or together with the nanoparticles, in bound form the nanoparticles may be endocytosed by the endothelial cells, followed by the release of the drugs within diflucan dangerous side effects these cells and the delivery to the brain solutol� hshydroxysterarate of peg and peg low content lipoid� lecithin � labrafac� triglycerides cc w purified water nacl this does not apply to diflucan dangerous side effects superficial skin tumors which can be recognized sometimes when tumors contain cell clusters of reaching mm diameter occasionally modern imaging techniques high resolution ct scan, mri can detect smaller mm findings diflucan dangerous side effects with suspected cancer features in asymptomatic individuals however, it is reasonable to assume that nonimaging techniques, for ex proteomics based, will be needed to safely break through the cancer cell mass diagnostic threshold stealth is a registered trademark of alza corp, mountain view, ca a general toxic effect on the brain vasculariture, leading to the permeabilization of the brain blood vessel endothelial cells